Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Ken-Pen Weng"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2734 (2024)
Asians have a higher carrier rate of pulmonary arterial hypertension (PAH)-related genetic variants than Caucasians do. This study aimed to identify PAH-related genetic variants using whole exome sequencing (WES) in Asian idiopathic and heritable PAH
Externí odkaz:
https://doaj.org/article/0489d235b1fe44d1870a13735ffe6ac4
Publikováno v:
Pediatrics and Neonatology, Vol 64, Iss 3, Pp 359-361 (2023)
Externí odkaz:
https://doaj.org/article/7d34b607d0fa467780c112cfb213f816
Publikováno v:
International Journal of Interactive Multimedia and Artificial Intelligence, Vol 6, Iss 7, Pp 101-108 (2021)
Doctors conventionally analyzed echocardiographic images for diagnosing congenital heart diseases (CHDs). However, this process is laborious and depends on the experience of the doctors. This study investigated the use of deep learning algorithms for
Externí odkaz:
https://doaj.org/article/fe13023914e24b509ca49a173132da08
Autor:
Humberto García Aguilar, Matthias Gorenflo, D. Dunbar Ivy, Shahin Moledina, Biagio Castaldi, Hidekazu Ishida, Paweł Cześniewicz, Jacek Kusa, Oliver Miera, Joseph Pattathu, Ken‐Pen Weng, Laszlo Ablonczy, Christian Apitz, Marta Katona, Kenichi Kurosaki, Tomas Pulido, Hiroyuki Yamagishi, Kazushi Yasuda, Galia Cisternas, Melanie Goth, Susanne Lippert, Anna Radomskyj, Soundos Saleh, Stefan Willmann, Gabriela Wirsching, Damien Bonnet, Maurice Beghetti
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 3, Pp n/a-n/a (2022)
Abstract Riociguat, a soluble guanylate cyclase stimulator, is approved for treatment of adults with pulmonary arterial hypertension (PAH). The safety, tolerability, and pharmacokinetics (PK) of oral riociguat in a pediatric population with PAH was a
Externí odkaz:
https://doaj.org/article/b9ede33b5c434f00ad5c57409c295608
Autor:
Jin-Hui Chung, Yi-Ju Tsai, Ko-Long Lin, Ken-Pen Weng, Ming-Hsuan Huang, Guan-Bo Chen, Sheng-Hui Tuan
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 4, p 167 (2023)
Individuals with mitral valve prolapse (MVP) have exercise intolerance even without mitral valve regurgitation. Mitral valve degeneration may progress with aging. We aimed to evaluate the influence of MVP on the cardiopulmonary function (CPF) of indi
Externí odkaz:
https://doaj.org/article/b6177317ca8c4a598afe5f9145a69ee8
Publikováno v:
Current Issues in Molecular Biology, Vol 43, Iss 2, Pp 485-500 (2021)
Kawasaki disease (KD) typically occurs in children aged under 5 years and can cause coronary artery lesions (CALs). Early diagnosis and treatment with intravenous immunoglobulin can reduce the occurrence of CALs; therefore, identifying a good biomark
Externí odkaz:
https://doaj.org/article/9042726165ed46e885a632ed1d3eb351
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 1, p 31 (2023)
Pulmonary stenosis (PS) affects cardiopulmonary function and exercise performance. Cardiopulmonary exercise testing (CPET) together with transthoracic echocardiography (TTE) can measure exercise performance, PS progression, and treatment effects. We
Externí odkaz:
https://doaj.org/article/14e3b545a1014b9d92df4abe453389d8
Autor:
Ko-Long Lin, I-Hsiu Liou, Guan-Bo Chen, Shu-Fen Sun, Ken-Pen Weng, Chien-Hui Li, Sheng-Hui Tuan
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
ObjectiveKawasaki disease (KD) is the most common form of pediatric vasculitis. We evaluated the influence of KD on cardiopulmonary function and analyzed the echocardiographic findings of patients with KD through serial follow-ups from childhood to a
Externí odkaz:
https://doaj.org/article/cc07610bae4b4c229377a0e3360b17b8
Autor:
Ken-Pen Weng, Kuang-Jen Chien, Shih-Hui Huang, Lien-Hung Huang, Pei-Hsien Lin, Yuyu Lin, Wei-Hsiang Chang, Chun-Yu Chen, Sung-Chou Li
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 21, p 12770 (2022)
Coronary artery lesions (CAL) are a major complication of Kawasaki disease (KD). The early prediction of CAL enables the medical personnel to apply adequate medical intervention. We collected the serum samples from the KD patients with CAL (n = 32) a
Externí odkaz:
https://doaj.org/article/041a3e08e30143b0b55c290e1e7fe6e2
Autor:
Chun-Yu Chen, Shih-Hui Huang, Kuang-Jen Chien, Tsung-Jen Lai, Wei-Hsiang Chang, Kai-Sheng Hsieh, Ken-Pen Weng
Publikováno v:
Children, Vol 9, Iss 9, p 1343 (2022)
Vascular endothelial growth factor (VEGF) is an important factor in mediating the inflammation of Kawasaki disease (KD). The literature regarding the relationship between VEGF and KD is sparse. The purpose of this study was to investigate the correla
Externí odkaz:
https://doaj.org/article/9fc0e46c987d4dc191e13d857a465ceb